The laboratory of Huda Zoghbi, where the discovery that mutations in the gene MECP2 cause the severe childhood neurological disorder Rett ...

The Rett Syndrome Research Trust (RSRT) is pleased to initiate two new gene therapy projects in the fight against Rett Syndrome. Both projects ...

A new non-profit organisation, the Rett Syndrome Research Trust UK (RSRT UK) launches today. Set up by the families of girls and women with Rett ...

Melior Discovery, Inc. announced today that it has entered into collaboration with the Rett Syndrome Research Trust to screen drug-candidates in ...

A paper published online today in Molecular Cell proposes that Methyl CpG binding protein 2 (MeCP2) impacts the entire genome in neurons, rather ...

The Rett Syndrome Research Trust (RSRT) announced today the creation of a Professional Advisory Council in support of RSRT’s goal of curing ...

The Rett Syndrome Research Trust announced today its financial support of an innovative research project with significant therapeutic potential. ...

The Rett Syndrome Research Trust announced today the appointment of Nobel Laureate J. Michael Bishop, Christopher Lipinski and Axel Unterbeck to ...

A paper published online today in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 (MeCP2) in glia. MeCP2 is a protein ...

The Rett Syndrome Research Trust, a newly established nonprofit organization, is pleased to announce the launch of our operations and website ...